Rabbit anti-Human MEN1 Polyclonal Antibody | anti-MEN1 antibody

MEN1 Rabbit Polyclonal

Cat. Num. AAA7601356

• Gene Names: MEN1; MEAI; SCG2
• Reactivity: Human
• Applications: ELISA, Western Blot
• Purity: >=95% as determined by SDS-PAGE; Immunogen Affinity Purified
• Synonyms: MEN1; Polyclonal Antibody; MEN1 Rabbit Polyclonal; anti-MEN1 antibody

• Host: Rabbit
• Reactivity: Human
• Clonality: Polyclonal
• Isotype: IgG
• Purity/Purification: >=95% as determined by SDS-PAGE; Immunogen Affinity Purified
• Form/Format: Liquid
• Sequence Length: 615

• Applicable Applications for anti-MEN1 antibody: ELISA (EIA), Western Blot (WB)
• Immunogen: Multiple endocrine neoplasia I
• Preparation and Storage: PBS with 0.02% sodium azide and 50% glycerol pH 7.3, -20 degree C for 24 months (Avoid repeated freeze / thaw cycles.)

Western Blot (WB)

(HepG2 cells were subjected to SDS PAGE followed by western blot with MBS7601356 (MEN1 antibody) at dilution of 1:500)

NCBI and Uniprot Product Information

• NCBI GI #: 18860851
• NCBI GeneID: 4221
• NCBI Accession #: NP_570713.1
• NCBI GenBank Nucleotide #: NM_130801.2
• Molecular Weight: 63,748 Da
• NCBI Official Full Name: menin isoform 1
• NCBI Official Synonym Full Names: menin 1
• NCBI Official Symbol: MEN1
• NCBI Official Synonym Symbols: MEAI; SCG2
• NCBI Protein Information: menin
• UniProt Protein Name: Menin
• Protein Family: Menin
• UniProt Gene Name: MEN1
• UniProt Synonym Gene Names: SCG2
• UniProt Entry Name: MEN1_HUMAN

NCBI Description

This gene encodes menin, a putative tumor suppressor associated with a syndrome known as multiple endocrine neoplasia type 1. In vitro studies have shown menin is localized to the nucleus, possesses two functional nuclear localization signals, and inhibits transcriptional activation by JunD, however, the function of this protein is not known. Two messages have been detected on northern blots but the larger message has not been characterized. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Oct 2008]

Uniprot Description

MEN1: Essential component of a MLL/SET1 histone methyltransferase (HMT) complex, a complex that specifically methylates 'Lys-4' of histone H3 (H3K4). Functions as a transcriptional regulator. Binds to the TERT promoter and represses telomerase expression. Plays a role in TGFB1-mediated inhibition of cell-proliferation, possibly regulating SMAD3 transcriptional activity. Represses JUND-mediated transcriptional activation on AP1 sites, as well as that mediated by NFKB subunit RELA. Positively regulates HOXC8 and HOXC6 gene expression. May be involved in normal hematopoiesis through the activation of HOXA9 expression. May be involved in DNA repair. Component of MLL-containing complexes (named MLL, ASCOM, MLL2/MLL3 or MLL3/MLL4 complex): at least composed ASH2L, RBBP5, DPY30, WDR5, one or several histone methyltransferases (MLL, MLL2, MLL3 and/or MLL4), and the facultative components MEN1, HCFC1, HCFC2, NCOA6, KDM6A, PAXIP1/PTIP and C16orf53/PA1. Interacts with POLR2A phosphorylated at 'Ser-5', but not with the unphosphorylated, nor 'Ser-2' phosphorylated POLR2A forms. Interacts with FANCD2 and DBF4. Interacts with JUND. Interacts with SMAD3, but not with SMAD2, nor SMAD4. Directly interacts with NFKB1, NFKB2 and RELA. Ubiquitous. 3 isoforms of the human protein are produced by alternative splicing.

Protein type: Transcription, coactivator/corepressor

Chromosomal Location of Human Ortholog: 11q13

Cellular Component: chromatin; cleavage furrow; cytoplasm; cytosol; histone methyltransferase complex; nuclear chromatin; nuclear chromosome, telomeric region; nuclear matrix; nucleoplasm; nucleus; protein complex

Molecular Function: chromatin binding; double-stranded DNA binding; four-way junction DNA binding; histone-lysine N-methyltransferase activity; protein binding; protein binding, bridging; protein N-terminus binding; Y-form DNA binding

Biological Process: brain development; decidualization; DNA repair; MAPKKK cascade; mitotic cell cycle; negative regulation of cell cycle; negative regulation of cell proliferation; negative regulation of cyclin-dependent protein kinase activity; negative regulation of epithelial cell proliferation; negative regulation of JNK cascade; negative regulation of osteoblast differentiation; negative regulation of protein amino acid phosphorylation; negative regulation of telomerase activity; negative regulation of transcription factor activity; negative regulation of transcription from RNA polymerase II promoter; negative regulation of transcription, DNA-dependent; osteoblast development; positive regulation of protein binding; positive regulation of transcription from RNA polymerase II promoter; positive regulation of transforming growth factor beta receptor signaling pathway; regulation of activin receptor signaling pathway; response to DNA damage stimulus; response to gamma radiation; response to UV; transcription, DNA-dependent

Disease: Multiple Endocrine Neoplasia, Type I